Home › Calculator › OPHLF Dividend Calculator 2026
OPHLF Dividend DRIP Calculator 2026
3.51% YieldHealthcareOno Pharmaceutical Co., Ltd. · OTC
Price: $14.86 · Annual div: $0.52/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When OPHLF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your OPHLF snowball 📈
$10,000 in OPHLF → $4.60M in 10 years · $13,299.39/month
About Ono Pharmaceutical Co., Ltd. (OPHLF) — Dividend Analysis 2026
Globally, Ono Pharmaceutical Co., Ltd., along with its affiliated entities, is engaged in the development, procurement, and commercialization of pharmaceutical products and diagnostic tools. Its product line features a wide array of therapeutic solutions, including several key oncology treatments such as OPDIVO, KYPROLIS, MEKTOVI, VELEXBRU, ADLUMIZ, and BRAFTOVI. It also offers EMEND and PROEMEND for managing chemotherapy-induced nausea and vomiting, and DEMSER for pheochromocytoma symptoms. For metabolic health, GLACTIV and FORXIGA target type 2 diabetes. The company provides medications for cardiovascular conditions (ONOACT for tachyarrhythmia, OPALMON for peripheral circulatory disorder, CORALAN for chronic heart failure) and autoimmune diseases (ORENCIA for rheumatoid arthritis). Neurological disorders are addressed with RIVASTACH for Alzheimer's and ONGENTYS for Parkinson's disease. Other significant offerings cover conditions such as overactive bladder (STAYBLA), bronchial asthma and allergic rhinitis (ONON), osteoporosis (RECALBON), and joint function improvement (JOYCLU), alongside PARSABIV for dialysis patients. Beyond its existing portfolio, the company maintains an active research and development pipeline, focusing on numerous therapeutic areas. This includes a broad spectrum of oncological conditions, such as various carcinomas (esophageal, urothelial, ovarian, bladder, prostate, hepatocellular, pancreatic, biliary tract, gastric, thyroid, colorectal, non-small cell lung), lymphomas (Hodgkin's, primary central nervous system), melanoma, acute myeloid leukemia, myelodysplastic syndrome, and virus-positive/negative solid tumors. Its developmental efforts also extend to inflammatory and autoimmune disorders like polymyositis/dermatomyositis, pemphigus, generalized scleroderma, and enthesopathy, as well as cardiovascular issues (tachyarrhythmia, thrombosis), neurodegenerative diseases, diabetic polyneuropathy, and conditions such as narcolepsy. Established in 1717, this long-standing enterprise operates from its main office in Osaka, Japan.
Compare OPHLF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full OPHLF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open OPHLF position with:
🌍 OPHLF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold OPHLF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.51% | 0.71% | $351 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.98% | 0.18% | $298 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.81% | 0.01% | $281 / yr |
| 🇬🇧 UK ISA | 0% | 3.51% | 0.71% | $351 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.20% | 0.40% | $320 / yr |
| 🇨🇦 TFSA | 0% | 3.51% | 0.71% | $351 / yr |
| 🇨🇦 CA Taxable | 25% | 2.63% | -0.17% | $263 / yr |
| 🇦🇺 Super (pension) | 15% | 2.98% | 0.18% | $298 / yr |
| 🇦🇺 AU Taxable | 30% | 2.46% | -0.34% | $246 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.58% | -0.22% | $258 / yr |
| 🇫🇷 FR Taxable | 30% | 2.46% | -0.34% | $246 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 OPHLF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.52/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 OPHLF Dividend Payment Schedule
OPHLF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 OPHLF vs Healthcare Benchmarks
How OPHLF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OPHLF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ OPHLF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OPHLF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Ono Pharmaceutical Co., Ltd. (OPHLF) is currently trading at $14.86, 11% below its 52-week high. The current dividend yield is 3.51% based on an annual payout of $0.52 per share.
OPHLF (Ono Pharmaceutical Co., Ltd.) — 3.51% Dividend Yield Analysis
Ono Pharmaceutical Co., Ltd. (OPHLF) is a healthcare stock currently trading at $14.86 with a dividend yield of 3.51%. The company pays an annual dividend of $0.52 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, OPHLF has grown its dividend at a compound annual rate of 78.7%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest OPHLF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.